Pacific Biosciences of California, Inc. provided revenue guidance for the fourth quarter and the fiscal year ended December 31, 2021. For the quarter, The company expects preliminary fourth quarter revenue of approximately $36.0 million, representing an increase of approximately 33% compared with $27.1 million for the fourth quarter of 2020.

For the year, the company expects preliminary annual 2021 revenue to be $130.5 million, representing a growth of approximately 65% from 2020.